Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 18-26, 2 January 2004

The health care costs of diabetic nephropathy in the United States and the United Kingdom☆

  • Adam Gordois

      Affiliations

    • York Health Economics Consortium Ltd., Market Square (Level 2), University of York, Vanbrugh Way, Heslington, York YO10 5NH, UK
    • ,
  • Paul Scuffham

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44-1904-434832; fax: +44-1904-433628
    • York Health Economics Consortium Ltd., Market Square (Level 2), University of York, Vanbrugh Way, Heslington, York YO10 5NH, UK
    • ,
  • Arran Shearer

      Affiliations

    • York Health Economics Consortium Ltd., Market Square (Level 2), University of York, Vanbrugh Way, Heslington, York YO10 5NH, UK
    • ,
  • Alan Oglesby

      Affiliations

    • Global Health Outcomes, Eli Lilly & Company, Indianapolis, IN, USA

Received 14 January 2003; received in revised form 17 February 2003; accepted 21 February 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ York Health Economics Consortium was a paid consultant of Eli Lilly & Company to undertake impartial research into the health care costs of diabetic nephropathy in the USA and the UK.

PII: S1056-8727(03)00035-7

doi:10.1016/S1056-8727(03)00035-7

Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 18-26, 2 January 2004

Article Tools

* Image Usage & Resolution